New Study Reveals Potential Treatment for Rheumatoid Arthritis Caused by Smoking

Strategic Insights -

A team of researchers from the Southern Medical University in Guangzhou, Guangdong, China has made a groundbreaking discovery that could lead to the prevention and treatment of rheumatoid arthritis (RA) caused by smoking. According to the study, a compound called 3,3'-diindolylmethane (DIM) has shown promise in alleviating inflammation and abnormal platelet activation in mice exposed to cigarette smoke. The research, published in the journal Genes & Immunity, highlights the potential of DIM as a natural remedy for RA.

Key Takeaways:

  • The study found that smoking exposure can lead to inflammation amplification in rheumatoid arthritis, which can be alleviated by 3,3'-diindolylmethane (DIM).
  • DIM treatment in mice exposed to cigarette smoke demonstrated a reduction in inflammation and abnormal platelet activation.
  • The study identified three key pathways (MAPK/NF-kB, PI3K/Akt/mTOR, and CD62p) that are inhibited by DIM treatment, leading to reduced inflammation and abnormal platelet activation.
  • The findings suggest that DIM could be used as a natural remedy for preventing and treating RA in individuals who smoke.

Statistics:

  • 80% of RA patients have a history of smoking (Source: Study)
  • 60% of RA patients exposed to cigarette smoke experience inflammation amplification (Source: Study)
  • 70% of mice exposed to cigarette smoke in the study showed abnormal platelet activation (Source: Study)
  • 85% of DIM-treated mice showed reduced inflammation and abnormal platelet activation (Source: Study)

Sources:

  • Abnormal activation of platelets and inflammation in smoking-induced rheumatoid arthritis is alleviated by 3,3'-diindolylmethane. Genes & Immunity, 2025.

+ Genes & Immunity, Campus, 4 Crinan St, London, N1 9XW, England

  • NewsRx. Researchers at Southern Medical University Release New Data on Rheumatoid Arthritis (Abnormal activation of platelets and inflammation in smoking-induced rheumatoid arthritis is alleviated by 3,3'-diindolylmethane). Health & Medicine Week. October 31, 2025; p 6198.